Pakistan vs Serbia: Cause of death, by non-communicable diseases, ages 60+, male
Pakistan
67.9%
in 2021
Serbia
68.6%
in 2021
Pakistan rank
97th
Serbia rank
95th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Pakistan
- Serbia
How they compare
Serbia currently reports 68.6% against 67.9% in Pakistan, a difference of 0.7%.
Across all 6 years both countries report, Serbia has been ahead every year.
Pakistan ranks 97th and Serbia ranks 95th of 185 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pakistan | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 78.9% | 95.1% | 16.2% | Serbia |
| 2010s | 83.3% | 95.1% | 11.8% | Serbia |
| 2020s | 70.0% | 74.8% | 4.8% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Pakistan or Serbia?
- Serbia, at 68.6% against 67.9% in Pakistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Pakistan and Serbia?
- 0.7%, with Serbia ahead.
- How many years of comparable data are there for Pakistan and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Pakistan and Serbia rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Pakistan ranks 97th and Serbia ranks 95th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.